Lipitor keeps on selling, so Pfizer will keep on producing it in Ireland

It's official: Demand for the off-patent drug Lipitor has inspired Pfizer ($PFE) to keep an Irish plant it had slated for closure. Sales in emerging markets, and to a lesser extent the U.S., are behind the change of mind, which saves 160 jobs in Little Island, Cork. Improved productivity at the plant helped, too. Release | More

Suggested Articles

The Pharma Lions shortlist for 2019 lives up to its name with just 31 entries making the cut. But it's still good news for the 12 drugmaker finalists.

Pharma companies filed suit Friday to block the new HHS rule that requires drugmakers to put list prices in TV ads.

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.